Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genes, Essential | 1 | 2020 | 40 | 0.710 |
Why?
|
| Embryonic Development | 1 | 2020 | 208 | 0.630 |
Why?
|
| Neoplasms | 2 | 2023 | 2697 | 0.580 |
Why?
|
| Twist-Related Protein 1 | 2 | 2023 | 36 | 0.340 |
Why?
|
| Estrogen Receptor alpha | 2 | 2021 | 449 | 0.280 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2023 | 217 | 0.240 |
Why?
|
| Nuclear Proteins | 2 | 2023 | 1280 | 0.220 |
Why?
|
| Breast Neoplasms | 3 | 2021 | 2478 | 0.210 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 879 | 0.190 |
Why?
|
| Cell Proliferation | 4 | 2021 | 2321 | 0.190 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 62 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 1351 | 0.170 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2019 | 72 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 1881 | 0.150 |
Why?
|
| Cell Survival | 1 | 2020 | 817 | 0.150 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 297 | 0.150 |
Why?
|
| Receptor, ErbB-2 | 1 | 2021 | 496 | 0.150 |
Why?
|
| Estrogens | 1 | 2019 | 505 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 669 | 0.120 |
Why?
|
| Models, Biological | 1 | 2020 | 1437 | 0.120 |
Why?
|
| Luciferases | 1 | 2015 | 137 | 0.120 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 1582 | 0.110 |
Why?
|
| Tamoxifen | 1 | 2015 | 363 | 0.110 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 3297 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 788 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 2 | 2021 | 602 | 0.070 |
Why?
|
| Humans | 6 | 2023 | 121798 | 0.060 |
Why?
|
| GATA3 Transcription Factor | 1 | 2021 | 37 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2021 | 49 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 94 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 111 | 0.050 |
Why?
|
| Oncogenes | 1 | 2021 | 171 | 0.050 |
Why?
|
| Tumor Burden | 1 | 2021 | 229 | 0.040 |
Why?
|
| Adult | 1 | 2020 | 28548 | 0.040 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2019 | 53 | 0.040 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2019 | 61 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2021 | 347 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2021 | 346 | 0.040 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2019 | 153 | 0.040 |
Why?
|
| Mice | 3 | 2021 | 17632 | 0.040 |
Why?
|
| Cell Movement | 1 | 2021 | 838 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 629 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2019 | 799 | 0.030 |
Why?
|
| Histones | 1 | 2019 | 528 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 714 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 213 | 0.030 |
Why?
|
| Animals | 3 | 2021 | 33878 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2015 | 572 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2015 | 254 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2015 | 807 | 0.030 |
Why?
|
| Female | 4 | 2021 | 64574 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 653 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2019 | 1933 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1401 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 1672 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4518 | 0.020 |
Why?
|